To clarify the mechanism by which FSTL3 plays a pro-oncogenic role in RCC, we further measured the profiles of the GSK-3β/β-catenin and BMP1/SMAD signals after up-regulating or down-regulating FSTL3. This evidence concerns the gene FSTL3 and renal cell carcinoma.